As a global key player in yeasts and fermentation, Lesaffre designs, manufactures and markets innovative solutions for Baking, Food taste & pleasure, Health care and Biotechnology.
Family group born in northern France in 1853, now a multi-national and a multicultural company, Lesaffre is committed to working with confidence to better nourish and protect the planet.
In close collaboration with its clients and partners, Lesaffre employs 11 000 people in more than 50 countries.
Lesaffre achieves a turnover of 3 billion euros.
Following recent investments in high-throughput microbial screening and genome editing platforms, the Lesaffre Institute for Science and Technology (LIST) seeks to expand its capacity in the fields of computational biology and bioinformatics.
As a Bioinformatician Research Associate, you will join the Biodata Center of Excellence. Our mission is to accelerate the development of Lesaffre products by leveraging multi-omics data and artificial intelligence. Our expertise spans diverse domains such as bioinformatics, comparative genomics and transcriptomics, metabolic engineering, high-dimensional statistics and deep learning. We act as an innovation enabler and catalyst, working in close collaborations with the various Business Units of Lesaffre and the other LIST Centers of Excellence, on a great variety of projects.
Your main responsibilities will be:
This role requires a combination of advanced bioinformatics and scientific software development skills, a collaborative mindset, and a focus on operational excellence to drive impactful outcomes for Lesaffre.
For this position, we require:
Prior experience in the following domains would be considered a plus:
What can Lesaffre offer you:
At Lesaffre, diversity is a strength that enriches our culture and our teams. We are committed to offering you a work environment where you can thrive, regardless of your background, gender, age or abilities. We encourage all applications, as we believe that diverse perspectives strengthen our ability to innovate and meet the challenges of tomorrow.